Instituto Hispalense De Pediatria S.L.

Sevilla 9 trials 1 recruiting

9 Registered trials

1 Currently recruiting

Organisation

Instituto Hispalense De Pediatria S.L.

Location

Sevilla, Spain

Identifier

ORG-100046933

Address

Calle Del Jardin De La Isla Num 6, 41014, Spain

Departments

ES007: Pediatría
Instituto Hispalense de Pediatria (IHP). Fundacion IHP. ( #1)
Medicina Interna
N/A
Pediatria
Pediatrics
Pediatrics Department

Clinical trials at this site (9)

Search interface

A Study to Learn About Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Infants Recruiting

2022-503070-36-00 Group B streptococcus (GBS) disease 5 2025-12-23
Safety and immunogenicity of an investigational Pentavalent Meningococcal ABCYW vaccine against meningococcal disease in children, toddlers,… Ended

2023-510465-10-00 Meningococcal immunization 4 2025-03-10
Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a 5- and/or 10-year Boo… Ended

2023-510145-25-00 Meningococcal infection 5 2022-08-23
A Phase 3 study to assess the immune response and safety of rMenB+OMV NZ in primed healthy participants (10 to 20 years old) Ended

2024-519549-31-00 Invasive meningococcal disease (IMD) 5 2025-09-05
Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers Ended

2023-505762-29-00 Virus diseases 5 2024-08-09
A Safety, Tolerability, and Immunogenicity Study of mRNA-1345 and mRNA-1365 in Participants Aged 5 Months to <24 Months Ended

2022-502022-41-00 Acute lower respiratory infection 3 2024-05-28
A Ph2 dose-finding study (MARS-17) to evaluate the efficacy and safety of GSK3858279 in adults with knee osteoarthritis pain. Ended

2022-502799-22-00 Knee osteoarthritis pain 4 2023-11-29
Evaluating the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age Ended

2023-508820-37-00 Cytomegalovirus Infection (CMV) 5 2022-02-03
MENACWY=MEN7B-003 Ended

2023-506449-40-00 Infections, Meningococcal 9 2021-11-29